image
mobile_image
headline

Pfizer's ABRYSVO® helps reduce your risk of RSV infection

content
You may be at increased risk of hospitalization from RSV if you are 60 and older. ABRYSVO is a vaccine indicated for the prevention of lower respiratory tract disease caused by RSV in people 60 years of age and older.

If you have not been vaccinated against RSV yet, talk to your pharmacist or doctor about ABRYSVO.
buttons
Find ABRYSVO
disclaimer
RSV=respiratory syncytial virus.
collection-container
grid-3
collection-item-type
core-card
card_identifier
mobile_image
heading

RSV may come with serious risks

body
RSV is a highly contagious virus that puts between 100,000 and 150,000 adults 60 and older in the hospital each year.
cta
Understand Your RSV Risk
card_identifier
heading

ABRYSVO can help protect you against RSV

body
A single dose of ABRYSVO can help protect you against this highly contagious virus. Vaccination with ABRYSVO may not protect all people.
cta
About ABRYSVO
card_identifier
heading

Find answers to some of your questions

body
Learn more about RSV and ABRYSVO with our Frequently Asked Questions.
cta
Go to FAQs
icon
headline
content
  • All adults 75 and older
  • Adults 60 and older with certain chronic conditions like asthma, COPD, heart disease and diabetes

See other risk factors here

buttons
See Important Safety Information
collection-container
grid-2
collection-item-type
core-card
card_identifier
heading

Learn about cost and coverage for ABRYSVO

body
Find the latest on coverage and possible assistance available.
cta
CTA Button Link
card_identifier
heading

Stay in the know about RSV and ABRYSVO

body
Sign up to get RSV information straight to your inbox or via text.
cta
CTA Button Link